Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Endocrine Pathology is Scopus-indexed (Q1, CiteScore 22.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 1046-3976Verify ISSN ↗1559-0097Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$3,190 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pathology and Forensic Medicine | 2 / 209 | 99th | Q1 |
| Endocrinology, Diabetes and Metabolism | 8 / 250 | 97th | Q1 |
| Endocrinology | 5 / 132 | 96th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1990–present, best quartile Q1, CiteScore 22.3.
Endocrine Pathology is Q1 in Pathology and Forensic Medicine (rank 2 of 209), Q1 in Endocrinology, Diabetes and Metabolism (rank 8 of 250) and Q1 in Endocrinology (rank 5 of 132), by CiteScore 2025.
Endocrine Pathology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 22.3, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.715, quartile Q1, with an H-index of 65.
The publisher lists an article processing charge of about US$3,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Endocrine Pathology is published by Springer. Its print ISSN is 1046-3976 and its online ISSN is 1559-0097.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Endocrine Pathology has an h-index of 76 and a 2-year mean of 5.29 citations per paper (OpenAlex). Its Scopus CiteScore is 22.3, quartile Q1. On 2-year citations it ranks #8 of 208 Scopus journals in Pathology and Forensic Medicine.
Endocrine Pathology published 53 papers in 2025; its busiest recent year was 2018 with 53. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from United States (19.2%), Italy (15.8%) and Germany (9.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.